What is the mission of big corporations in the healthcare business? How is AI going to impact the drug development continuum in the next 5-10 years? How essential is the MBA for doctors who want non-traditional careers? In this episode, we answer all these questions and more with our guest, Sachin H. Jain, M.D.
Sachin is the president and CEO of SCAN Group and Health Plan, an HMO, which provides healthcare coverage to Medicare beneficiaries throughout California, currently serving nearly 200,000 members. SCAN is one of the largest NPO Medicare Advantage Prescription Drug plans in the country.
Before this, Sachin was Chief Medical Information & Innovation Officer at Merck & Co. He graduated magna cum laude from Harvard College with a BA in government and continued to earn his MD from Harvard Medical School and MBA from Harvard Business School. He trained in medicine at Brigham and Women's Hospital.
Join us as Lincoln Nadauld, CEO of Culmination Bio, delves into the crucial role of genomics-powered precision medicine in Oncology research. Discover the main...
Why is there a mismatch between VC companies and some vulnerable patient populations? Do we need a radical transformation from the ground up of...
What factors must we overcome for healthcare Machine Learning to reach its full potential? How can LMICs globally be included in the healthcare informatics...